P

Inventor

VERHOEVEN THOMAS R

US35 patents
⚠️ This page may combine multiple inventors who share the name “VERHOEVEN THOMAS R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

32 patents
US4820850AApr 11, 1989

Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof

MERCK & CO INC154 citations99
US4582915AApr 15, 1986

Process for C-methylation of 2-methylbutyrates

MERCK & CO INC61 citations96
US4611067ASep 9, 1986

Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein

MERCK & CO INC57 citations95
US5399771AMar 21, 1995

Process of synthesizing binaphthyl derivatives

MERCK & CO INC37 citations92
US5834502ANov 10, 1998

Triazolylmethyl-indole ethylamine bisulfate salt

MERCK & CO INC18 citations88
US4645854AFeb 24, 1987

Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit

MERCK & CO INC22 citations81
US4620025AOct 28, 1986

Process for the preparation of biphenyl intermediates

MERCK & CO INC13 citations74
US4584389AApr 22, 1986

Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one

MERCK & CO INC9 citations74
US5596113AJan 21, 1997

Ruthenium-phosphine complex catalysts for asymmetric hydrogenations

MERCK & CO INC12 citations72
US5567824AOct 22, 1996

Palladium catalyzed ring closure of triazolyltryptamine

MERCK & CO INC16 citations72
US5424432AJun 13, 1995

Process for the preparation of imidazolutidine

MERCK & CO INC17 citations71
US5508435AApr 16, 1996

Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or gamma-ketoamides

MERCK & CO INC14 citations70
US6333435B1Dec 25, 2001

Process of synthesizing binaphthyl derivatives

MERCK & CO INC12 citations69
US5420353AMay 30, 1995

Regiospecific process to make cis-1-amino-2-alkanol from epoxide

MERCK & CO INC8 citations69
US5693816ADec 2, 1997

Process for the preparation of diisopinocampheylchloroborane

MERCK & CO INC5 citations68
US5292946AMar 8, 1994

In-situ preparation of diisopinocamphenyl chloroborane

MERCK & CO INC10 citations68
US5858737AJan 12, 1999

Conversion of indene to (1S)-amino-(2R)-indanol free of any stereoisomer, by combination of dioxygenase bioconversion and chemical steps

MERCK & CO INC6 citations67
US4866186ASep 12, 1989

Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof

MERCK & CO INC4 citations63
US4845237AJul 4, 1989

Acylation process for the synthesis of HMG-CoA reductase inhibitors

MERCK & CO INC4 citations62
US4582914AApr 15, 1986

Process for the preparation of HMG-CoA reductase inhibitors

MERCK & CO INC3 citations62
US5124448AJun 23, 1992

Deblocking process for allyl esters with regeneratable polymer supported Pd(O)

MERCK & CO INC5 citations61
US5545758AAug 13, 1996

Process for the preparation of diisopinocampheylchloroborane

MERCK & CO INC2 citations60
US5605819AFeb 25, 1997

Quantitative conversion of indene to (1S,2R) indene oxide and (1S,2R)-indandiol by combination of haloperoxidase bioconversion and chemical steps

MERCK & CO INC4 citations59
US4876364AOct 24, 1989

Hydrogenation process for the formation of 4A,5-dihydro HMG-CoA reductase inhibitors

MERCK & CO INC6 citations57
US4831165AMay 16, 1989

Hydrogenation process for the formation of 3,4-dihydro HMG-CoA reductase inhibitors

MERCK & CO INC4 citations57
US4697037ASep 29, 1987

Preparation of dibenzo[b,f]thiepin compounds

MERCK & CO INC0 citations52
US5489710AFeb 6, 1996

Regiospecific processes to make cis-1-amino-2-alkanol from diol

MERCK & CO INC1 citations51
US5484923AJan 16, 1996

Process of making spirocycles and analogs thereof

MERCK & CO INC1 citations51
US4864035ASep 5, 1989

Hydrogenation process for the formation of tetrahydro HMG-CoA reductase inhibitors

MERCK & CO INC1 citations51
US4826999AMay 2, 1989

Hydrogenation process for the formation of 3,5-dihydro HMG-CoA reductase inhibitors

MERCK & CO INC1 citations51
US5693812ADec 2, 1997

Polymorphic forms of an angiotensin II antagonist

MERCK & CO INC1 citations49
US5099033AMar 24, 1992

Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists

MERCK & CO INC0 citations42

MARCK & CO INC

1 patent

MERCK FROSST CANADA INC

1 patent

WISCONSIN ALUMNI RES FOUND

1 patent